Planning permission granted for Cambridge Biomedical Campus

Cambridge City Council has given formal planning consent for development of the Cambridge Biomedical Campus to go ahead.

 

Cambridge University Hospitals and its partners – Countryside Properties, Liberty Property Trust, the Medical Research Council and the University of Cambridge – can now begin the next stage of the site’s expansion, which will include the relocation of Papworth Hospital and will enhance Cambridge’s reputation as an international centre for patient care, biomedical research and education.

 

The Cambridge Biomedical Campus will cover 140 acres rather than the current 70 occupied by Addenbrooke’s and the Rosie, providing room for extensive new clinical facilities including Papworth, the children’s hospital, and expanded services for maternity, neurosciences, and cancer.

 

It will also include University of Cambridge facilities and research labs like the new Medical Research Council Laboratory of Molecular Biology, where world-class scientists can work to push back the boundaries of medical knowledge. The campus will be home to one of the largest and most internationally-competitive concentrations of health-related talent and enterprise in Europe.

 

Stephen Graves, Director of Corporate Development, said:

 

“We’re delighted that the City Council has given us permission to take this unique plan forward. Together with our partners, the expansion will put us at the forefront of institutions that combine excellent clinical care, teaching and research on one site. Our ambition is to become the best biomedical research centre in Europe, and I know that patients will benefit both from the new facilities and from the discoveries that will be made.”

 

As well as Addenbrooke’s and the Rosie, organisations currently on the campus include:

• Addenbrooke’s Centre for Clinical Investigation (ACRC and WTCRF)
• Brain Repair Centre
• Cambridge Biomedical Research Centre – part of the NIHR
• Cambridge Institute for Medical Research
• Cambridge University Health Partners
• Cancer Research UK Cambridge Research Institute
• GlaxoSmithKline Clinical Research Unit
• Herschel Smith Centre for Brain and Mind Sciences
• Hutchison/MRC Research Centre
• Institute of Metabolic Science
• Institute for Public Health
• MRC Centre for Protein Engineering
• MRC Laboratory of Molecular Biology
• MRC Mitochondrial Biology Unit
• National Blood and Transplant Service
• Strangeways Research Laboratory
• University of Cambridge School of Clinical Medicine
• West Forvie Centre
• Wolfson Brain Imaging Centre

 

The proposed developments include:

• Papworth Hospital
• Rosie Hospital expansion
• Children’s Hospital
• Comprehensive cancer centre
• Emergency Department
• Critical Care
• New operating theatres
• Neurosciences centre
• Infectious diseases facilities

 

Cambridge University Hospitals’ partners in the development of the Cambridge Biomedical Campus are Countryside Properties, Liberty Property Trust, the Medical Research Council, the Pemberton Trustees, and the University of Cambridge. The Addenbrooke’s Access Road and the Cambridgeshire Guided Busway, which are essential to the site’s success, are being developed by Cambridgeshire County Council and supported by Cambridgeshire Horizons.

 

 

 

 

 

 

Back to top